ABOUT US
Your Early Phase Research Consultancy supporting Biotech, MedTech and Pharmaceutical industry in aligning with vendors in Australia.
Experienced subject matter experts in Clinical Trials offering highly skilled services and support for your early phase needs, while providing you with the necessary knowledge to build your research from the base up.
Our Services
Our Expertise
Early Phase, Phase II and Phase III
-
First in Human
-
SAD/MAD
-
BioSimilars
-
Food Effect
-
Oncology,
-
Neuroscience,
-
Mental Health
-
Dermatology
-
Vaccines
-
Rare diseases
-
Urology
-
Ophthalmology.
Australian Advantage
Outsourcing early-phase clinical trials to Australia offers significant benefits for sponsors.
Firstly, Australia provides cost advantages through attractive research and development (R&D) tax incentives, reducing the financial burden of trials.
Secondly, the Australian clinical trial process is efficient and flexible, saving time and resources without compromising quality. Australia's robust research infrastructure ensures high-quality outcomes, with a strong network of universities, research institutes, and CROs.
Outsourcing to Australia offers a compelling proposition combining cost-efficiency, speed, and quality. Furthermore, Australia's streamlined regulatory process eliminates the need for mandatory IND applications and full GMP standards for early-phase trials, providing flexibility and cost savings.